Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMM

NCT06205823 · clinicaltrials.gov ↗

UNKNOWN

Status

1600

Enrollment

OTHER

Sponsor class

Conditions

Myeloma Multiple

Interventions

DRUG: Immunotherapy

Sponsor

Seoul St. Mary's Hospital